Artificial Organs
Abiomed Receives Proposed National Coverage Decision from CMS for AbioCor(R) Total Replacement Heart
Published in Medical Letter on the CDC and FDA, February 24th, 2008
"This proposed decision is a positive development for the advancement of our AbioCor program in the United States," said Michael R. Minogue, Chairman, President and CEO of Abiomed. "This decision by CMS provides momentum towards making the technology available for chronic patients who require bi-ventricular support and have no other treatment options."
CMS proposed coverage with evidence development of artificial heart devices and also proposes to cover artificial...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Drug Development
Study of successful drug targets could hasten development of new medications - Metabolism
Marshfield Clinic Research Team Uses Affymetrix DMET Solution to Discover Genetic Variant Affecting Warfarin Metabolism in Patients - Schizophrenia
Research data from A. Khan and colleagues update understanding of schizophrenia - Synthetic Blood International Inc.
Synthetic Blood Announces Medical Advisory Board Meeting Results, New Additions to Board - Life Sciences
New pediatric in children research reported from University of Colorado - Life Sciences
Research from University of Colorado yields new findings on pediatric in children - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
